ArticlePain reports2026
D1 and D2 neurons in medial nucleus accumbens participate in chronic orofacial pain phenotypes.
Article in Pain reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Differential roles of dopamine D1 and D2 receptors in pain modulation: a review.Frontiers in neurologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Trigeminal nerve injuries can lead to different outcomes, such as chronic neuropathic pain. Nevertheless, it is still elusive why different phenotypes of chronic pain development are shown among individuals. Nucleus accumbens (NAc) might be important for chronic pain development. Still, the role of this structure and its neural subpopulations on these phenotypes development in the orofacial region remains unknown. Objectives: To evaluate the role of dopamine D1- and D2-receptor-expressing neurons (D1Rn and D2Rn) of medial NAc (mNAc) in developing phenotypes of chronic orofacial pain. Methods: C57BL/6 male and female mice underwent a trigeminal nerve compression injury and were assessed with the von Frey test for nociceptive threshold on day 3 and from weeks 1 to 14. To determine the role of mNAc D1Rn and D2Rn, transgenic D1R-Cre and D2R-Cre mice were infected with a genetically engineered caspase, causing specific ablation of such neurons. Results: All the injured C57BL/6 mice showed mechanical hypersensitivity during the first weeks. On week 2, mice were classified into high and low threshold (HT and LT). Most HT mice recovered from mechanical hypersensitivity, whereas most LT mice remained hypersensitive during all assessment weeks. Both mNAc D1Rn and D2Rn ablation decreased the percentage of HT mice, and D2Rn ablation increased the time of hypersensitivity recovery, suggesting these populations participate in both nociceptive threshold profiles and recovery capacity. Conclusion: mNAc D1Rn and D2Rn might play an important role in determining the phenotypes of chronic orofacial pain development after a nervous injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.